| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/27/2023 | Neumora Therapeutics, Inc. | | Purchase | Common Stock | 24.5k | $12.31 | $301.6k | By ARCH Venture Fund XII, L.P. | 09/26/2023 |
| 09/26/2023 | Neumora Therapeutics, Inc. | | Purchase | Common Stock | 34k | $11.73 | $398.8k | By ARCH Venture Fund XII, L.P. | 09/26/2023 |
| 06/08/2023 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (Right to Buy) | 35k | $1.26 | $44.1k | | 06/08/2023 |
| 06/06/2023 | Beam Therapeutics Inc. | BEAM | Grant | Stock Option (Right to Buy) | 16.5k | $34.33 | $567.5k | | 06/06/2023 |
| 09/01/2022 | Beam Therapeutics Inc. | BEAM | Grant | Stock Option (Right to Buy) | 10.4k | $55.58 | $577.5k | | 09/01/2022 |
| 06/09/2022 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (Right to Buy) | 30k | $7.02 | $210.6k | | 06/09/2022 |
| 05/26/2022 | Scholar Rock Holding Corp | SRRK | Grant | Stock Option (Right to Buy) | 28k | $4.75 | $133k | | 05/26/2022 |
| 06/30/2021 | Beam Therapeutics Inc. | BEAM | Other (acquisition) | Common Stock | 2k | $0.00 | $0 | | 06/30/2021 |
| 06/30/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 06/30/2021 |
| 06/30/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 06/30/2021 |
| 06/29/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 06/25/2021 |
| 06/29/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 06/25/2021 |
| 06/29/2021 | Beam Therapeutics Inc. | BEAM | Other (acquisition) | Common Stock | 2k | $0.00 | $0 | | 06/25/2021 |
| 06/25/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 06/25/2021 |
| 06/25/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 06/25/2021 |
| 06/25/2021 | Beam Therapeutics Inc. | BEAM | Other (acquisition) | Common Stock | 2k | $0.00 | $0 | | 06/25/2021 |
| 06/24/2021 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 25k | $4.18 | $104.5k | | 06/24/2021 |
| 06/10/2021 | Beam Therapeutics Inc. | BEAM | Grant | Stock Option (Right to Buy) | 6.9k | $87.91 | $604.6k | | 06/10/2021 |
| 06/09/2021 | Gossamer Bio, Inc. | GOSS | Grant | Stock Option (Right to Buy) | 23.5k | $8.97 | $210.8k | | 06/09/2021 |
| 05/27/2021 | Scholar Rock Holding Corp | SRRK | Grant | Stock Option (Right to Buy) | 7.8k | $26.78 | $208.9k | | 05/27/2021 |
| 05/24/2021 | Metacrine, Inc. | MTCR | Grant | Stock Option (right to buy) | 16.5k | $4.07 | $67.2k | | 05/24/2021 |
| 03/31/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 03/31/2021 |
| 03/31/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 03/31/2021 |
| 03/31/2021 | Beam Therapeutics Inc. | BEAM | Other (acquisition) | Common Stock | 2k | $0.00 | $0 | | 03/31/2021 |
| 03/22/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 03/18/2021 |
| 03/22/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 03/18/2021 |
| 03/22/2021 | Beam Therapeutics Inc. | BEAM | Other (acquisition) | Common Stock | 2k | $0.00 | $0 | | 03/18/2021 |
| 03/18/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 03/18/2021 |
| 03/18/2021 | Beam Therapeutics Inc. | BEAM | Other (disposition) | Common Stock | 200k | $0.00 | $0 | See footnote | 03/18/2021 |
| 03/18/2021 | Beam Therapeutics Inc. | BEAM | Other (acquisition) | Common Stock | 2k | $0.00 | $0 | | 03/18/2021 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Purchase | Common Stock | 20k | $13.00 | $260k | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series A Convertible Preferred Stock | 2M | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series B Convertible Preferred Stock | 472.3k | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series C Convertible Preferred Stock | 138.7k | $0.00 | $0 | See footnote | 09/18/2020 |
| 09/18/2020 | Metacrine, Inc. | MTCR | Conversion | Series C Convertible Preferred Stock | 138.7k | $0.00 | $0 | See footnote | 09/18/2020 |
|